Domann in the News

Our more than twenty five year commitment supporting the entrepreneurial spirit continues with our ongoing sponsorship of conferences, symposiums and educational forums focused on bringing emerging growth companies together with investors, venture capitalists, and industry professionals.

You’ll find the latest Domann news below

2018’s Fiercest Women in Life Sciences

Things are looking up for women—or so they seem. In the era of #MeToo, more and more women are speaking up about workplace harassment and discrimination, and the perpetrators are increasingly held accountable. Industry groups, like the Biotechnology Innovation Organization (BIO), and states, such as California, are implementing rules to increase the proportion of women on corporate boards.

That’s encouraging. But in a way, these advances only highlight the hurdles professional women still face, even women at the top of their fields.

Take Donna Strickland, who won this year’s Nobel Prize in physics, and Frances Arnold, who won the Nobel Prize in chemistry. They are two of three female Nobel laureates in this year’s field of 12 prize winners. Yet, until about an hour and a half after Strickland’s award was announced, the optical physicist was not considered important enough to have her own Wikipedia page. She shares the Nobel Prize for physics with two men; her colleague Gérard Mourou has had his own Wikipedia entry since 2005.

Life sciences is little different. Women fill half of the industry’s entry-level positions, but make up only 20% of leadership teams and 10% of boards, according to a study conducted by MassBio and LiftStream (PDF).

Individual companies and industry groups have come up with programs to help move women up the ladder. After LifeSci Advisors threw a model-staffed J.P. Morgan after-party in 2016—prompting widespread outrage—the company rehabbed its image by starting a “Boardroom Ready” program aimed at placing more women on boards.

And in a letter this October, BIO issued new targets for female representation at the highest ranks of its member companies. The letter raises the 2025 target for women at the functional leader and C-suite level to 50% from the current 25%. At the board level, BIO wants to see women in 30% of the industry’s board seats by 2025 rather than the current level of 10%. But that ultimatum came only after its own controversial party—this year’s Party At BIO Not Associated with BIO—where topless women danced, their bodies painted with the logos of investment groups and biotech companies sponsoring the event.

Still, programs can only work if there’s a diverse pool of talent to choose from, and that’s something this year’s fiercest women are working to develop.

Sara Kenkare-Mitra, Genentech’s senior vice president of development sciences, emphasized the importance of “investing in the next generation of female—and male—scientists and leaders.”

“We believe that by investing time, expertise and resources in science education, we can help ensure a talented and diverse pipeline of STEM professionals for the future,” she said.

Many of our honorees came of age when few women occupied high-level positions. While most women at smaller companies didn’t have a chance at formalized mentoring, they did have invaluable mentors and coaches along the way. Now, as their companies grow large enough to support formal programs, many are paying it forward, formally or informally coaching employees earlier in their careers.

Their most common piece of advice for women looking to advance? Be bold. It can seem as if an opportunity comes too soon, before a woman feels qualified. But Synlogic CEO Aoife Brennan and GlaxoSmithKline CMO Kate Knobil, M.D., tell women to try it anyway.

“It seems like women want to be overqualified before they put themselves up for a position, whereas a man might say, ‘Well, I might not have all the experience, but I can do that.’ So I encourage women to think that way, too. Don’t wait to be 100% qualified before putting yourself forward,” Knobil said.

Equally important is asking for the next step, said Marion Dorsch, Ph.D., chief scientific officer of Blueprint Medicines.
“Make sure that your supervisor and the people around you know where you want to go and what your ambitions are. Don’t be shy to ask for help and ask for ways to develop in the direction you want to.”
Read on to learn more about this year’s fiercest women in life sciences. They join the women honored in last year’s list, our first to include women from the medtech sector, and those on the 2016 list

2018’s Fiercest Women in Life Sciences

  • Hanne Bak—Regeneron
  • June Bray—Allergan
  • Aoife Brennan—Synlogic
  • Jennifer Carver—La Jolla Pharma
  • Beth-Ann Coller—Merck
  • Marion Dorsch—Blueprint Medicines
  • Maria Fardis—Iovance Biotherapeutics
  • Susan Galbraith—AstraZeneca
  • Vinita Gupta—Lupin
  • Kimi Iguchi—Sage Therapeutics
  • Sara Kenkare-Mitra—Genentech
  • Kate Knobil—GlaxoSmithKline
  • Andrea Miller—Mylan
  • Melissa Moore—Moderna Therapeutics
  • Melanie Nallicheri—Foundation Medicine
  • Rebecca Holland New—Thermo Fisher
  • Arleen Paulino—Amgen
  • Shalini Sharp—Ultragenyx
  • Andrea Spezzi—Orchard Therapeutics
  • Susan Sweeney—Bristol-Myers Squibb

DOMANN sponsors MichBio Expo October 29-30, 2018

The MichBio Expo is Michigan’s Premier Bioscience Event!

The 2018 MichBio Expo & Conference, sponsored by the Michigan Economic Development Corporation (MEDC) will feature prominent keynote/plenary speakers and panelists who will focus on the latest in technology, business practice innovation and industry growth across the spectrum of sectors over the past 25 years. The Conference promises to be an incredible opportunity for knowledge-sharing, information gathering and networking for Michigan’s bio-industry representatives.

DOMANN attends AGTECH and supports Funding Opportunities for Startups- October 2, 2018

AGTECH – Funding Opportunities for Startups
www.agtechday.com
AgTech Day can help meld all three through emerging companies in fields such as precision farming, food packaging, food safety, organics, resource conservation and more. ” Parts of rural Wisconsin and the Midwest look to re-energize their economic foundations and communities, agriculture technology is a natural platform.

LUNCH SPEAKER

CHRISTOPHER P. SALM, PHD

Founder, CEO & Chairman of the Board for Ab E Discovery, LLC
Founder and Board Member of Ab E Manufacturing, LLC
Founder and Board Member of Salm Partners, LLC

Throughout his career, Chris has focused on building trusted relationships while finding and proving new technologies to better feed the world. He has nearly 40 years of experience at the forefront of innovation in the meat industry and held leadership positions at Oscar Mayer, Johnsonville Sausage, and ConAgra Foods. At age 50, Chris left the security of employment in a structured company setting to apply his passion to changing the world through new technology applications of science and engineering.

Chris holds a B.S. in meat and animal sciences from the University of Wisconsin-Madison and M.S. and Ph.D. degrees from Purdue University. Over the past 8 years, Chris has served as chairman of two advisory boards for the Dean of the College of Agriculture and Life Sciences at U-W Madison and is currently on the UW-Madison College of Agriculture and Life Sciences Board of Visitors. Chris is a 2016 University of Wisconsin Entrepreneurial Achievement Award recipient.

Program Emcee

TOM STILL

President
Wisconsin Technology Council

Tom Still is president of the Wisconsin Technology Council. The Tech Council is the non-profit, bipartisan science and technology policy advisory board to the governor and the Legislature. Its programs include the Tech Council Investor Networks, the Tech Council Innovation Network, the Governor’s Business Plan Contest and regular events that connect entrepreneurs, investors, researchers and others with a stake in the tech-based economy.

Still serves on the Governor’s Council on Workforce Investment, the UW System Business Council, the Badger Fund of Funds Limited Partners Advisory Committee, the Governor’s Special Committee on Autonomous and Connected Vehicles, and advisory groups for the UW-Madison College of Engineering, the UW-Madison Department of Computer Sciences and the WiSys Technology Foundation, among other civic and business groups. He is the former associate editor of the Wisconsin State Journal in Madison. Still writes a syndicated column that appears regularly in more than two-dozen publications. Still is a senior lecturer in the Department of Life Sciences Communication in the UW-Madison College of Agricultural and Life Sciences.

DOMANN – BIO Investor Conference 2018- San Francisco, CA.

“Conference focused on early and established private companies as well as emerging public companies”
The BIO Investor Forum, organized by the Biotechnology Industry Organization will take place from 17th October to the 18th October 2018 The Westin St. Francis San Francisco on Union Square in San Francisco, United States Of America. BIO Investor Forum will be an all-inclusive forum that shall provide opportunity to the individual researchers, Private equity and public investors, industry executives focusing on investment and business development to share experience and insight on investment possibilities of private and public companies mainly in the domain of life science.BIO Investor Forum will conduct business roundtable and therapeutic workshops, plenary talks, company presentation along with one on one exclusive meeting which will reduce all contentions on evaluating fresh investment opportunities with a special focus on drug development with available tools and technologies. Moreover, the opportunity to network with top-level industry executive will make it an obvious choice for the regional and global attendees.

California Becomes 1st State To Require Women On Corporate Boards

October 2018

California will be the first state to require publicly traded companies to have at least one woman on their board of directors.
The law, signed by Gov. Jerry Brown on Sunday, requires public companies whose principal executive offices are located in California to comply by the end of 2019. The minimum is two female directors if the company has five directors on its board, or three women if it has seven directors by the close of 2021.

“Domann Celebrating 30 years-1988 to 2018”

September 2018

The Domann Organization, Inc. – Life Science Leadership

Celebrating 30 Years
1988 – 2018

Founded in San Francisco during the biopharmaceutical industry’s infancy, The Domann Organization – Life Science Leadership is proud to be celebrating 30 years of success. Building game-changing leadership teams is not only our profession…it’s our passion.

Find out why the most innovative companies and investment firms partner with Domann on Board, Chief Executive Officer, C-Suite and other senior functional hires.

In today’s competitive business environment, it is paramount to be represented by an established firm with a commanding market presence, global reach, and reputation for results.

Our firm specializes in therapeutics, diagnostics/tools, digital health, ag-biotech, and animal health. We operate from offices in San Francisco, San Diego, Los Angeles, California, and Madison, Wisconsin and work in the United States, Europe, A-PAC and Israel.

As a retained practice, we’re dedicated to assuring our Clients, privately held and public biopharmaceutical and healthcare companies, secure the key executive and board talent that adds and creates immediate value, helping them capitalize on growth opportunities.

Statistics speak volume. All of our searches are performance driven. We have a completion rate of 95%. The average hire is completed within 85 calendar days and remains with our Clients five-plus years, with many being promoted during their tenure. With 90% of Domann’s business being repeat or referral we feel we must be doing something right.

When considering search, we encourage you to consider Domann

Executive search that delivers!

www.domann.net

Domann participating in Baird Life Sciences Conference NYC

September 2018

Charles Winter, formerly with Denali Therapeutics joins Synthorx, Inc. La Jolla, CA as Vice President, CMC.

Synthorx Expands Leadership Team:
07.12.18

SAN DIEGO, July 12, 2018 – Synthorx, Inc., a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, announced today the appointment Charles M. Winter, Vice President, Chemistry, Manufacturing, and Controls (CMC).

“We are pleased to add these talented individuals – each with an impressive track record of leadership and significant accomplishments and experience – to our team,” said Laura Shawver, Ph.D., President, CEO, and Director of Synthorx. “We believe each of them will be important to Synthorx as we advance our pipeline of Synthorin™ cytokines, including Synthorin IL-2, and pursue our goal of demonstrating that our technology can create tailored medicines that offer improvements over current treatments with the ability to help people with serious diseases.”

Mr. Charles M. Winter has deep experience in advancing biologic manufacturing in all phases of the drug development pipeline, as well as important expertise in managing U.S. and ex-U.S. regulatory interactions. Prior to Synthorx, he was Head of Biologics CMC for the Denali Therapeutics pipeline. Before joining Denali, Mr. Winter was Vice President, Manufacturing and Technology at JHL Biotech, where he executed strategic deals for developing and manufacturing biologics in Taiwan and China. Previously at Gilead and at Genentech, Mr. Winter was a core member of a start-up team for a new GMP facility and developed processes for multiple investigational new drug applications. Mr. Winter received a B.S. in chemical engineering from University of Wisconsin-Madison.

About Synthorx

Synthorx, Inc. is a biotechnology company using synthetic biology to discover and develop novel protein therapeutics. Synthorx’s expanded genetic alphabet platform has the ability to drive the site-specific incorporation of multiple synthetic amino acids into proteins, thereby tuning receptor specificity important for improving efficacy and safety. In addition, the company’s engineered organisms provide the ability to manufacture these improved proteins, called Synthorins, with the required fidelity and yield. The Synthorx platform expands the chemical and structural repertoire of protein therapeutics and uncovers new ways to modulate pharmacological properties of biologics. The company was founded based on important discoveries in Dr. Floyd Romesberg’s lab at The Scripps Research Institute in conjunction with Avalon Ventures. The company is headquartered in La Jolla, Calif.

The Domann Organization has created three scholarships to students at Menomonee Falls High School, Bill’s Alma Mater.

June 2018

The three: A Fine Arts Scholarship (Music, Art, Literature, Drama) a Life Sciences Scholarship (medical, healthcare) and a Community Services Scholarship (church, scouting, social and business organizations)

Domann attending the Wisconsin Entrepreneur’s Conference in Madison, Wisconsin

June 2018

Parvus Therapeutics Appoints Dr. Curtis Ruegg as Chief Executive Officer

May 2018

Burlingame, CA – (BUSINESS WIRE) – Parvus Therapeutics, a biopharmaceutical company developing disease-modifying nanomedicines to halt or reverse autoimmune disease without causing general immune suppression, announced today the appointment of Curtis Ruegg, Ph.D., as Chief Executive Officer and a member of the Company’s Board of Directors. Dr. Ruegg brings to Parvus over 25 years of leadership experience in the biopharmaceutical industry. Domann- Life Science Leadership conducted the successful search and recruitment of Dr. Ruegg.

TAI Diagnostics, Wauwatosa, Wisconsin announces Michael Klass, Ph.D. is their new Head, Product Development & Technical Operations.

May 2018

Steve Gullans, Ph.D. named Chief Executive Officer of Gemphire Therapeutics, Inc. Livonia, Michigan

May 2018

Domann-the Board Room Inc. confidentially retained by public San Diego Life Sciences company to recruit an Independent Director.

April 2018

ChemioCare, Inc. New York City, announces Julien Howell, M.D. as their Chief Medical Advisor.

March 2018

ChemioCare, Inc. New York City, announces Julien Howell, M.D. as their Chief Medical Advisor.

Synthorx, Inc. San Diego, CA retains Domann to recruit Head, CMC

March 2018

Bill Domann attending the Bio CEO conference in New York City.

February 2018

TAI Diagnostics, Inc. Milwaukee, Wisconsin retains Domann to recruit a Head, Research & Product Development.

February 2018

Gregor Diagnostics, Inc. Madison, Wisconsin adds Bob Wolfert and Jason Christiansen to its Scientific Advisory Board

February 2018

Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer. Gregor’s patient-friendly test will be the first diagnostic to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. This will result in decreased overdiagnosis and overtreatment of indolent prostate cancer, and more effective detection of aggressive prostate cancer.

To receive a list of the Domann organizations search activity for 2017 or to contact Domann about a search that you may be considering in 2018.

January 2018

Please reach out to Jovanna Bost, Chief Business Officer/Partner at jbost@domann.net.

Gemphire Therapeutics, Inc. Livonia, Michigan retains Domann-The Board Room Inc. to recruit a Chief Executive Officer

January 2018

ChemioCare, Inc. New York City retains Domann to recruit Chief Medical Officer

January 2018

Domann-The Board Room Inc. launches Chief Executive Officer search for Parvus Therapeutics, Inc. Calgary/San Francisco

January 2018

FluGen, Madison Wisconsin announces C. Boyd Clarke Has Been Named Executive Chairman

September 2017

Gregor Diagnostics and the Wisconsin Alumni Research Foundation (WARF) have entered into an exclusive license agreement.

May 2017

Domann opens 4th office in Los Angeles, California

May 2017

Domann continues to support the Midwest Life Sciences community with memberships in BioForward, the Wisconsin Technology Council, iBIO and MichBio

May 2017

The Guardsmen of San Francisco “Service to Youth since 1947” elects, David E. Cookson, A. Horton Shapiro, Thomas H. Power and William A. Domann, Jr. to the Guardsmen Hall of Fame

April 2017

Biotech Showcase -Domann Exclusive Search Firm Sponsor, San Francisco, January 9 to 11, 2017

January 2017

SAN FRANCISCO, CA – January 7, 2015-Domann, Life Science Leadership- Executive Search That Delivers today announced their firm, The Domann Organization, Inc, as the exclusive search sponsor at The Biotech Showcase to be held in San Francisco January 11-13, 2016. “We are excited to continue Domann’s long standing tradition of sponsoring premier Industry events focused on promoting the entrepreneurial spirit of the Life Sciences” stated Bill Domann, Founder and Chief Executive Officer. “The Biotech Showcase provides a compelling vehicle for us to support a conference platform focused on emerging life science companies that drives innovation and deals, we are honored to participate and look forward to an outstanding and productive conference”. Domann has entered into an exclusive multi-year agreement with EBD Group.

The Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees representing over 1250 companies. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. To achieve our mission, we created a variety of partnering conferences that today have grown to become the largest and most productive conference platform in the industry. Each one of our eight landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. EBD’s events annually attract more than 10,000 senior life science executives who engage in tens of thousands of one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in the life science industry.

About Domann, Inc:
The Domann Organization, Inc., is a retained search firm focused exclusively on delivering human capital. Founded in San Francisco during the biopharmaceutical industry’s infancy, Domann has built their practice by leveraging strategic industry knowledge and insight, relationship development, and talent cultivation. Their investment has resulted in Domann’s demonstrated advantage of securing the proven leadership talent providing the greatest potential for their Client’s strategic growth and success. Domann recruits Board, Chief Executive Officer, C-Suite, and other senior functional executives.

Recent client’s include: Ultragenyx Pharmaceuticals, NantKwest, CytomX Therapeutics, ArmaGen Inc., Deltanoid Pharmaceuticals, Assembly Biosciences, Parvus Therapeutics, and Swift Biosciences. Domann operates from three strategically located offices: San Francisco, San Diego, and Madison, WI with International partners in Europe and Asia Pacific.In 2014 Domann established The BOARD Room, Inc., to further complement and strengthen their existing practice. BOARD Room trends toward Board, Board Advisor, and Advisor Consultant work.

For additional information regarding Domann please visit the website at www.domann.net

Domannn contact Jovanna Bost, Vice President, Business Development at jbost@domann.net.

The Domann Organization continue to sponsor, support and attend the Early Stage Symposium Conference in Madison

November 2016

The Domann Organization, members of the Wisconsin Technology Council/Wisconsin Innovation Network continue to sponsor, support and attend the Early Stage Symposium Conference held in Madison every November.

The symposium is designed to unlock Wisconsin’s entrepreneurial potential by providing the right combination of ideas, innovation, intellectual property and investment – as well as hands-on instruction and advice targeted to early stage companies ready to make the leap.

It’s time to start planning for healthcare’s busiest week!
January 9–11, 2017 in San Francisco

October 2016

Registration numbers for Biotech Showcase™ are already up and we are forecasting another great event during the industry’s most important annual gathering. Presenting company slots are filling up fast and many hotels are already booked!

Domann, Life Science Leadership- Executive Search That Delivers today announced their firm Domann-The Board Room Inc. will continue as the exclusive search sponsor at The Biotech Showcase to be held in San Francisco January 9-11, 2017. “We are excited to continue Domann’s long standing tradition of sponsoring premier Industry events focused on promoting the entrepreneurial spirit of the Life Sciences” stated Bill Domann, Founder and Chief Executive Officer. “The Biotech Showcase provides a compelling vehicle for us to support a conference platform focused on emerging life science companies that drives innovation and deals, we are honored to participate and look forward to an outstanding and productive conference”. Domann has entered into an exclusive multi-year agreement with EBD Group.
The Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees representing over 1250 companies. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. To achieve our mission, we created a variety of partnering conferences that today have grown to become the largest and most productive conference platform in the industry. Each one of our eight landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. EBD’s events annually attract more than 10,000 senior life science executives who engage in tens of thousands of one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in the life science industry.

About Domann, Inc:
The Domann Organization, Inc., is a retained search firm focused exclusively on delivering human capital. Founded in San Francisco during the biopharmaceutical industry’s infancy, Domann has built their practice by leveraging strategic industry knowledge and insight, relationship development, and talent cultivation. Their investment has resulted in Domann’s demonstrated advantage of securing the proven leadership talent providing the greatest potential for their Client’s strategic growth and success. Domann recruits Board, Chief Executive Officer, C-Suite, and other senior functional executives.

For additional information regarding Domann please visit the website at www.domann.net

Domann contact Jovanna Bost, Vice President, Business Development at jbost@domann.net.

Domann-The Board Room Inc. will be attending the John G. Watson Quick Pitch Competition

October 2016

Tech Coast Angels, one of the largest and most active angel investing organizations in the United States with more than 300 members in five regional networks will host the 10th anniversary event where technology startups will compete for cash awards.

DOMANN CELEBRATES 15 YEARS IN SAN DIEGO

SEPTEMBER 2016

Domann established in San Francisco in 1988 and opened our San Diego office in September of 2001 would like to thank the clients we have served over the past 15 years.

Allergan PLC on Tuesday said it agreed to acquire Tobira Therapeutics Inc., a biopharmaceutical company that develops therapies for liver diseases, in a deal worth as much as $1.7 billion, or 19 times Tobira’s previous market value.

September 2016

Tobira focuses on products that treat nonalcoholic steatohepatitis, or NASH, a common liver disease associated with obesity and type-2 diabetes. NASH occurs when the accumulation of liver fat is accompanied by inflammation and cellular damage, and it can lead to scarring of the liver and progress to cirrhosis, liver cancer and eventual liver failure.

Domann invited to attend Baird’s Healthcare Conference in New York September 7 & 8. 103 companies (94 public, nine private) attended the event, up from 88 last year. Baird hosts fireside chats, presentations, and investor dinners with company management teams.

September 2016

Domann-The Board Room Inc. will be attending the 2016 Wisconsin Biohealth Summit on September 27th. The event offers an opportunity to exchange ideas, learn new strategies, and create lasting partnerships with companies at the forefront of their industry.

Join us at the 2016 Wisconsin Biohealth Summit!

September 27th, 2016 Overture Center, Madison, WI

unnamed

Domann-The Board Room Inc. continues to support the Michigan Growth Capital Symposium; Ypsila, Michigan

May 2016

The Michigan Growth Capital Symposium is the premier venture event that annually showcases nearly 40 “Best of the Midwest” high-growth companies in new businesses and emerging technologies. As part of MGCS, the newly added “University Pitch Track” will feature emerging startups out of the University of Notre Dame, Indiana University, University of Michigan, University of Chicago…

Biotech Showcase 2016 Reports Record High Attendance This Year- Domann Key Leadership Sponsor

January 2016

CARLSBAD, Calif., and NEW YORK and SAN FRANCISCO, Jan. 27, 2016 /PRNewswire/ — A record number of life science industry executives attended the eighth annual Biotech Showcase™ investor and networking conference, held January 11–13 in San Francisco.

More than 2,500 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from 1,600 companies and participated in 5,650 one-to-one investor meetings.

Over 300 innovative company presentations took place featuring mid-small cap and private life sciences across the therapeutic spectrum as well as platform, diagnostic and tool companies hoping to pique the interest of the nearly 600 public, private and strategic investors in attendance.

“The widespread commercialization of the biotech industry presented life sciences investors and industry leaders with new opportunities and challenges this year as they gathered for this year’s Biotech Showcase. We are proud that the event has become a home base for the life sciences industry during the healthcare industry’s busiest week of the year,” said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors.

“Although 2015 has been a volatile year for biotech, Biotech Showcase attendance is at an all time high. This speaks to the sustained interest within the investor community in biotech innovation,” said Anna Chrisman, Group Managing Director, EBD Group. “This year we provided more space, more one-on-one meetings which we hope resulted in more opportunities. It was overwhelmingly successful.”

Biotech Showcase is produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of producing high quality programs supporting the biotechnology and broader life sciences industry.

Biotech Showcase is powered by partneringONE®, the industry’s most advanced meeting system that enables delegates to efficiently identify and arrange meetings with potential investors.

Up-to-date coverage of Biotech Showcase, including panel videos and interviews, can be found on the Biotech Showcase website, onpartnering360:Insight, and on the partnering360 Blog.

The next edition of Biotech Showcase will be held January 9–11, 2017 in San Francisco.

Biotech Showcase -Domann Exclusive Search Sponsor, San Francisco, January 11-13, 2016

January 2016

SAN FRANCISCO, CA – January 7, 2015-Domann, Life Science Leadership- Executive Search That Delivers today announced their firm, The Domann Organization, Inc, as the exclusive search sponsor at The Biotech Showcase to be held in San Francisco January 11-13, 2016. “We are excited to continue Domann’s long standing tradition of sponsoring premier Industry events focused on promoting the entrepreneurial spirit of the Life Sciences” stated Bill Domann, Founder and Chief Executive Officer. “The Biotech Showcase provides a compelling vehicle for us to support a conference platform focused on emerging life science companies that drives innovation and deals, we are honored to participate and look forward to an outstanding and productive conference”. Domann has entered into an exclusive multi-year agreement with EBD Group.

The Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees representing over 1250 companies. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. To achieve our mission, we created a variety of partnering conferences that today have grown to become the largest and most productive conference platform in the industry. Each one of our eight landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. EBD’s events annually attract more than 10,000 senior life science executives who engage in tens of thousands of one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in the life science industry.

About Domann, Inc:
The Domann Organization, Inc., is a retained search firm focused exclusively on delivering human capital. Founded in San Francisco during the biopharmaceutical industry’s infancy, Domann has built their practice by leveraging strategic industry knowledge and insight, relationship development, and talent cultivation. Their investment has resulted in Domann’s demonstrated advantage of securing the proven leadership talent providing the greatest potential for their Client’s strategic growth and success. Domann recruits Board, Chief Executive Officer, C-Suite, and other senior functional executives.

Recent client’s include: Ultragenyx Pharmaceuticals, NantKwest, CytomX Therapeutics, ArmaGen Inc., Deltanoid Pharmaceuticals, Assembly Biosciences, Parvus Therapeutics, and Swift Biosciences. Domann operates from three strategically located offices: San Francisco, San Diego, and Madison, WI with International partners in Europe and Asia Pacific.In 2014 Domann established The BOARD Room, Inc., to further complement and strengthen their existing practice. BOARD Room trends toward Board, Board Advisor, and Advisor Consultant work.

For additional information regarding Domann please visit the website at www.domann.net

Domannn contact Jovanna Bost, Vice President, Business Development at jbost@domann.net.

Three to be added to Menomonee Falls High School Wall of Recognition

December 2015

Menomonee Falls — An accomplished doctor and two chief executive officers will join the ranks on the Wall of Recognition at Menomonee Falls High School this year.

A sincere sense of giving back in a variety of ways is the common denominator that has earned William Domann, Jr., Tom Gross and Jacquelyn Marie (McLees) Paykel a place on the Wall of Recognition, according to creator Dick Woosencraft.

“I know all of this year’s inductees personally, and they are all very special people,” said Woosencraft, who created the Wall of Recognition, Fine Arts Hall of Fame and Athletic Hall of Fame in his final year as principal at the high school.

Now in its 12th year, the wall features alumni who have accomplished powerful things since they walked the school halls.

The public is invited to attend as this year’s inductees are honored at halftime during the boys varsity basketball game Friday, Dec. 11, at the school, W142N8101 Merrimac Drive. There will also be a reception following the game in the school media center.

William Domann, Jr.

Family roots run deep in Menomonee Falls for Domann, whose family legacy began in the village in 1918 when his grandfather, William G. Domann, started his medical practice and would later become one of the founders of Community Memorial Hospital.

Beyond that, Domann, Jr. credits his parents, both of whom served as president of the Menomonee Falls Historical Society, for instilling him with a drive to give back to the community.

In 1988, Domann, Jr. founded the Domann Organization, which assists early-stage life sciences companies in building executive leadership teams and boards. Today, the organization has offices in San Francisco and San Diego, California, as well as in Madison.

Domann, who lives in California with his wife and two daughters, has served on many nonprofit boards, including the San Francisco Boys & Girls Club, the northern California Arthritis Foundation, The Guardsmen-San Francisco and BioForward.

Tom Gross

From a very young age, Gross always knew what he wanted to do when he grew up. A passion for electricity developed into a lifelong career for Gross, who recently retired from his final role as vice chairman and chief operating officer for Eaton Corporation.

Before his retirement, he was responsible for Eaton’s global electrical business, which includes $14 billion of annual sales in more than 175 countries. One of his recent moves was to locate Eaton’s research and development center to Menomonee Falls, which in 2013 joined Prague, Czech Republic; Pune, India; and Southfield, Michigan, as one of four key research and development centers.

During his tenure at Eaton, Gross was responsible for acquisitions in Europe, China, the Middle East and the United States. He and his wife have lived throughout the country and in Europe. In addition to Eaton, Gross spent more than 20 years at Rockwell Automation, primarily in the Milwaukee area.

In addition to being on the board of governors of the National Electrical Manufacturer’s Association before retirement, Gross currently serves on as a board member of RPM, Inc., a publicly traded specialty coatings company with multiple brands, including Rust-Oleum paint.

Jacquelyn Marie (McLees) Paykel

Finding ways to live life to the fullest is of the utmost importance to Paykel, who has accomplished a lot since she graduated in 1981.

Since graduation, she has lived in Chile as an exchange student; graduated from medical school; completed a residency in obstetrics and gynecology; served in the United States Navy; and has practiced in private, academic and government facilities.

In addition, she has completed a fellowship in integrative medicine, published papers and engaged in public-speaking events, including appearances on television to share her views on women’s health.

But most importantly to her, she has raised three sons together with Stuart Paykel, a fellow 1981 Menomonee Falls alumnus.

AT A GLANCE

WHAT:Menomonee Falls High School Wall of Recognition induction

WHEN:Halftime during the varsity boys basketball game Friday, Dec. 11

WHERE:Menomonee Falls High School, W142 N8101 Merrimac Drive

The Domann Organization continue to sponsor, support and attend the Early Stage Symposium Conference in Madison

November 2015

The Domann Organization, members of the Wisconsin Technology Council/Wisconsin Innovation Network continue to sponsor, support and attend the Early Stage Symposium Conference held in Madison every November.

The symposium is designed to unlock Wisconsin’s entrepreneurial potential by providing the right combination of ideas, innovation, intellectual property and investment – as well as hands-on instruction and advice targeted to early stage companies ready to make the leap.

Human Longevity Inc. (HLI) Acquires Cypher Genomics, Inc.

November 2015

(SAN DIEGO, CA)—November 30, 2015—Human Longevity Inc. (HLI), the genomics based, informatics driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions. The San Diego-based company has 14 employees who will join HLI including Cypher CEO and co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI’s Pediatric Business. Financial details of the deal were not disclosed.

“Cypher Genomics has created important automated and scalable genome interpretation technology informed by additional expertise in genetics and biology that we believe will be invaluable to HLI’s business. The Cypher team, led by Dr. Van Zeeland, is a very impressive group of scientists who will be crucial in augmenting HLI’s already unparalleled and comprehensive genomic database business,” said J. Craig Venter, Ph.D., Co-founder and CEO, HLI.
Cypher has developed and marketed Mantis™, proprietary software which provides comprehensive and unbiased interpretation of genomic sequencing data enabling customers to rapidly uncover clinically significant variants. The company has also developed Coral™, a biomarker discovery service.

Industry collaborators for these products include: Celgene, Illumina and Sequenom. Cypher also has a number of key academic collaborations including: Scripps Translational Science Institute, University of Pennsylvania, and Clinic for Special Children. Cypher, in partnership with Lockheed Martin, was also recently selected as one of the finalists in the Genomics England bidding process to aid in genome interpretation as part of their 100,000 Genomes Project.
“At Cypher we saw an unmet need for automated interpretation of human genome sequencing data. We developed Mantis and Coral to provide rapid, automated, genome interpretation at scale enabling disease gene identification, population-based studies, diagnostic development and biomarker identification,” said Dr. Van Zeeland. “We look forward to joining the HLI team and to help advance HLI’s mission of applying the power of human genomics and informatics to improve healthcare.”

HLI has created the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. The company is developing and applying large-scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. HLI enables customers in the pharmaceutical, biotechnology, insurance, academic and government sectors.

About Human Longevity Inc™.

Human Longevity Inc. (HLI) is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. HLI’s business also includes the HLI Health Nucleus, a genomic powered clinical research program which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health.

Domann sponsors the Michigan Growth Capital Symposium; Ypsila, Michigan

May 19-20, 2015

The Michigan Growth Capital Symposium is the premier venture event that annually showcases nearly 40 “Best of the Midwest” high-growth companies in new businesses and emerging technologies. As part of MGCS, the newly added “University Pitch Track” will feature emerging startups out of the University of Notre Dame, Indiana University, University of Michigan, University of Chicago…

Domann continues support as an annual sponsor the MidAmerica Healthcare Venture Forum.

March 6-7, 2015

The MidAmerica Healthcare Venture Forum gives promising early-stage companies a chance to pitch their products, business model or investment opportunity to active, eager angel, venture and strategic investors. Last year, companies presented in front of the likes of…

Domann continues membership and support to the Corporate Directors Forum

February 2015

Corporate Directors Forum is a nonprofit organization (501C-6) founded in 1991 to promote high standards of professionalism and ethics in the area of corporate governance and provide tools to help directors excel in the boardroom.

Core Values and Beliefs

  • Boards are strategic assets of corporations.
  • Education makes better directors.
  • Better directors make boards more effective.
  • More effective boards make better corporations.
  • We can all learn a lot from each other.

The Domann Organization’s “The Board Room, Inc.” is the first retained search firm to join The Water Council

January 2015

The Domann Organization’s “The Board Room, Inc.” is the first retained search firm to join The Water Council with an emphasis on providing CEO, Advisors and Independent Board members to start up companies.

The Water Council, the only organization of its kind in the United States, is successfully coalescing these tremendous attributes together into a powerful force. Created by leaders in both business and education, The Water Council is convening the region’s existing water companies and research clusters, developing education programs to train our talent, and building partnerships that cut across all sectors and geographic boundaries.

Milwaukee numbers among the world’s most significant hubs for water research, education, technology development and industry. Due to the work of The Water Council, a plethora of recent accomplishments have accelerated the region’s global impact and prestige.

For additional information on the Water Council please visit the website www.thewatercouncil.org

Domann launches The Board Room, Inc.

December 2014

The Domann Organization announced the formation of The Board Room Inc. The Board Room Inc., complements Domann’s existing recruitment platform with an emphasis on CEO, Board and Board Advisor searches. With private companies filing IPO’s at an unheard of pace and the exciting wave of entrepreneurial startups entering the marketplace, the dynamics and demand for quality Board Members and Advisors has dramatically increased. Our extensive network of leadership talent means we have immediate access and the unique ability to provide the steady and qualified hand of tenured leadership in the form of CEO, Board and Advisor leadership. For additional information on The Board Room Inc. please visit www.domann.net or www.BoardRoomInc.net.

The Domann Organization continue to sponsor, support and attend the Early Stage Symposium Conference in Madison

November 2014

The Domann Organization, members of the Wisconsin Technology Council/Wisconsin Innovation Network continue to sponsor, support and attend the Early Stage Symposium Conference held in Madison every November.

The symposium is designed to unlock Wisconsin’s entrepreneurial potential by providing the right combination of ideas, innovation, intellectual property and investment – as well as hands-on instruction and advice targeted to early stage companies ready to make the leap.

The 27th Biotech Meeting, Laguna Beach, CA

October 12-14, 2014

Bill Domann attends the gathering in Laguna Beach with industry CEO’s to discuss and review the industry’s current events.

BIO 2014 – San Diego, CA Domann hosts CEO/Board lunch

June 23, 2014 – June 26, 2014

The BIO International Convention is hosted by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

BIO performs many services for members, but none of them are more visible than the BIO International Convention. The BIO International Convention helps BIO fulfill its mission to help grow the global biotech industry. Profits from the BIO International Convention are returned to the biotechnology industry by supporting BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.

Bill Domann, Founder and CEO of The Domann Organization, Inc., elected to the Board of Directors of BIOforward and recently Co-Chaired the search selection committee to recruit the new CEO

January 2014

BIOforward, founded in 1987, is the member driven state association that is the voice of Wisconsin’s bioscience industry and a state chapter of the national Biotechnology Industry Organization, actively advocating on members behalf for public policy that supports the industry while providing opportunities for connections to funding, partners, and valuable resources. Members include key players from bioscience companies, universities, non-profits, service providers, investment capital firms, and government agencies.

Domann sponsors the Midwest Research University Network

October 8, 2013 – October 9, 2013

CATTEC VI
Leveraging connections for venture growth across the Midwest and beyond – CATTEC VI meets October 8-9, 2013 at Illinois Science + Tech Park in Skokie, IL.

Domann continues to support InvestMidwest Conference Kansas City, Kansas/St. Louis, Missouri

April 2013

InvestMidwest provides an opportunity for high growth companies from throughout the Midwest to present to an audience of over three hundred attendees including 60 -70 venture capital investors. The conference includes three presentation tracks: life sciences, technology and for the first time a food/ag/bioenergy presentation track.

The conference will showcase 45 companies in the three presentation tracks of life sciences, IT/general business and food/ag/bioenergy.